TNFRSF4 antibody (Middle Region)
Quick Overview for TNFRSF4 antibody (Middle Region) (ABIN929123)
Target
See all TNFRSF4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Purification
- Purified
-
Immunogen
- TNFRSF4 antibody was raised in rabbit using the middle region of TNFRSF4 as the immunogen
-
-
-
-
Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
TNFRSF4 Blocking Peptide, (ABIN938748), is also available for use as a blocking control in assays to test for specificity of this TNFRSF4 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
-
Alternative Name
- TNFRSF4
-
Background
- The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5. Knockout studies in mice suggested that this receptor promotes the expression of apoptosis inhibitors BCL2 and BCL2lL1/BCL2-XL, and thus suppresses apoptosis. The knockout studies also suggested the roles of this receptor in CD4+ T cell response, as well as in T cell-dependent B cell proliferation and differentiation. Synonyms: Polyclonal TNFRSF4 antibody, Anti-TNFRSF4 antibody, tumor necrosis factor receptor superfamily, member 4 antibody, ACT35 antibody, CD134 antibody, OX40 antibody, TXGP1L antibody.
-
Pathways
- Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-